Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stellate Ganglion Block and Facial Nerve Block for Idiopathic Facial Paralysis
NCT04800666Completed
- Start
- Mar 2021
- Primary completion
- Mar 2022
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
- Countries
- 1
01
Overview
Randomised, open-label trial of mecobalamin and ropivacaine in Bell's palsy (4 arms). Primary endpoints: House-Brackmann Grading System at 2 months and Sunnybrook Facial Grading System at 2 months. Started Mar 2021; status: completed.
02
Drugs
mecobalaminropivacaine
03
Conditions
Bell's palsy
Beyond the preview
Go deeper on NCT04800666.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04800666.